Innovent Biologics, Inc., a biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People's Republic of China, the United States, and internationally. The company discovers, develops, manufactures, and commercializes monoclonal antibodies and other drugs for the treatment of oncology, ophthalmology, autoimmune, cardiovascular, and metabolic diseases. Its commercial stage product portfolio includes TYVYT (sintilimab injection), BYVASDA...
Industry: Biotechnology
Sector: Healthcare
Phone: 86 512 6956 6088
Fax: 86 512 6956 6088
Address:
168 Dongping Street, Suzhou Industrial Park, Suzhou, China
